ATE225942T1 - Peptidereagenz zum nachweis von humanem cytomegalovirus (cmv) - Google Patents

Peptidereagenz zum nachweis von humanem cytomegalovirus (cmv)

Info

Publication number
ATE225942T1
ATE225942T1 AT97932819T AT97932819T ATE225942T1 AT E225942 T1 ATE225942 T1 AT E225942T1 AT 97932819 T AT97932819 T AT 97932819T AT 97932819 T AT97932819 T AT 97932819T AT E225942 T1 ATE225942 T1 AT E225942T1
Authority
AT
Austria
Prior art keywords
cmv
detection
antibodies
human cytomegalovirus
peptide reagent
Prior art date
Application number
AT97932819T
Other languages
English (en)
Inventor
De Crommert Johannes Marti Van
Jaap Michiel Middeldorp
Original Assignee
Organon Teknika Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Teknika Bv filed Critical Organon Teknika Bv
Application granted granted Critical
Publication of ATE225942T1 publication Critical patent/ATE225942T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/085—Orthoherpesviridae (F), e.g. pseudorabies virus or Epstein-Barr virus
    • C07K16/089—Cytomegalovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT97932819T 1996-07-12 1997-07-09 Peptidereagenz zum nachweis von humanem cytomegalovirus (cmv) ATE225942T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96201972 1996-07-12
PCT/EP1997/003717 WO1998002746A1 (en) 1996-07-12 1997-07-09 Peptide reagent for the detection of human cytomegalovirus (cmv)

Publications (1)

Publication Number Publication Date
ATE225942T1 true ATE225942T1 (de) 2002-10-15

Family

ID=8224180

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97932819T ATE225942T1 (de) 1996-07-12 1997-07-09 Peptidereagenz zum nachweis von humanem cytomegalovirus (cmv)

Country Status (12)

Country Link
US (1) US6936251B2 (de)
EP (1) EP0960336B1 (de)
JP (1) JP4218985B2 (de)
KR (1) KR100624517B1 (de)
AT (1) ATE225942T1 (de)
AU (1) AU735981B2 (de)
DE (1) DE69716305T2 (de)
DK (1) DK0960336T3 (de)
ES (1) ES2187796T3 (de)
ID (1) ID19063A (de)
WO (1) WO1998002746A1 (de)
ZA (1) ZA976196B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19919121B4 (de) * 1999-04-27 2012-08-02 F. Hoffmann-La Roche Ag Multimeres CMV-Antigen
JP4099058B2 (ja) 2000-10-20 2008-06-11 シティ・オブ・ホープ ヒトサイトメガロウィルスｐｐ１５０の免疫反応性ペプチドｃｔｌエピトープ
AUPR593101A0 (en) * 2001-06-26 2001-07-19 Council Of The Queensland Institute Of Medical Research, The Cytomegalovirus t cell epitopes
ITMI20012160A1 (it) * 2001-10-18 2003-04-18 Edoardo Marchisio Sistema immunoenzimatico per la caratterizzazione antigenica dell'infezione attiva da cytomegalovirus e cmv confirmation test
US7947274B2 (en) 2007-01-04 2011-05-24 Humabs, LLC. Human cytomegalovirus neutralising antibodies and use thereof
GB0700133D0 (en) 2007-01-04 2007-02-14 Humabs Llc Human cytomegalovirus neutralising antibodies and use thereof
CN101605808A (zh) * 2007-02-07 2009-12-16 希格马托制药工业公司 人巨细胞病毒(hcmv)的重组抗原
PT3009449T (pt) 2008-07-16 2018-09-28 Inst Res Biomedicine Anticorpos neutralizantes de citomegalovírus humano e utilização destes
WO2010148541A1 (zh) * 2009-06-26 2010-12-29 鑫品生医科技股份有限公司 含衍生自细胞巨大病毒的胜肽的免疫原组成物及使用方法
JP5712513B2 (ja) * 2010-07-07 2015-05-07 富士レビオ株式会社 ヒトサイトメガロウイルス感染の検出方法
NZ591514A (en) * 2011-03-03 2013-11-29 Kode Biotech Ltd Assay method
US10611800B2 (en) 2016-03-11 2020-04-07 Pfizer Inc. Human cytomegalovirus gB polypeptide
US11629172B2 (en) 2018-12-21 2023-04-18 Pfizer Inc. Human cytomegalovirus gB polypeptide
US11857622B2 (en) 2020-06-21 2024-01-02 Pfizer Inc. Human cytomegalovirus GB polypeptide
CN116298269A (zh) * 2022-08-17 2023-06-23 浙江大学医学院附属第一医院 人类巨细胞病毒重组抗原特异性IgG抗体的酶联免疫检测试剂盒

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987003602A1 (fr) * 1985-12-06 1987-06-18 Teijin Limited Anticorps monoclonal humain contre le virus megalocytique et procede de preparation dudit anticorps
CA1335429C (en) * 1986-03-07 1995-05-02 Geoffrey L. Smith Processes for the production of hcmv glycoproteins, antibodies thereto and hcmv vaccines, and recombinant vectors therefor
DE3619902A1 (de) * 1986-06-13 1988-03-03 Biotechnolog Forschung Gmbh Cmv-dna-strukturen, expressionsvektor dafuer, cmv-proteinstrukturen und deren verwendung
ATE132533T1 (de) * 1988-02-24 1996-01-15 Behringwerke Ag Strukturelles phosphoprotein (pp28) des menschlichen cytomegalovirus (hcmv), seine herstellung und verwendung
GB9014652D0 (en) * 1990-07-02 1990-08-22 Wellcome Found Antigen
DE4128684A1 (de) 1991-08-29 1993-03-04 Behringwerke Ag Hcmv-spezifische peptide, mittel dazu und ihre verwendung
US5744298A (en) 1991-08-29 1998-04-28 Behringwerke Aktiengesellschaft DNA sequences which encode immunoreactive HCMV-specific peptides
IT1266740B1 (it) * 1994-07-01 1997-01-14 Maria Paola Landini Materiale proteico ricombinante legante anticorpi contro il citomegalovirus umano, reagenti diagnostici derivati da tale
EP0702083A3 (de) 1994-07-26 1997-01-15 Biotest Ag Polypeptide und Fusionsproteine bestehend aus dem UL 57 Leserahmen bzw. dem C-terminalen Bereich des Tegumentproteins pp150 aus HCMV, entsprechende Oligonucleotide und Nachweis reagentien
DE4426453C1 (de) * 1994-07-26 1995-11-02 Biotest Ag Rekombinant hergestellte Fusionsproteine des Cytomegalievirus und diese enthaltende diagnostische Testkits

Also Published As

Publication number Publication date
US20030119039A1 (en) 2003-06-26
JP2000514300A (ja) 2000-10-31
EP0960336A1 (de) 1999-12-01
ZA976196B (en) 1998-09-01
DK0960336T3 (da) 2003-02-10
AU735981B2 (en) 2001-07-19
AU3623197A (en) 1998-02-09
KR100624517B1 (ko) 2006-09-18
DE69716305D1 (de) 2002-11-14
DE69716305T2 (de) 2003-06-26
JP4218985B2 (ja) 2009-02-04
WO1998002746A1 (en) 1998-01-22
ES2187796T3 (es) 2003-06-16
KR20000023701A (ko) 2000-04-25
ID19063A (id) 1998-06-11
US6936251B2 (en) 2005-08-30
EP0960336B1 (de) 2002-10-09

Similar Documents

Publication Publication Date Title
DE69716305D1 (de) Peptidereagenz zum nachweis von humanem cytomegalovirus (cmv)
DK104093D0 (da) Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen
NO963371L (no) Hematopoietisk protein samt materialer og fremgangsmåter for fremstilling av det
SE9500023D0 (sv) Method of detecting cancer
BR9712298A (pt) Polipeptìdeo, molécula de dna, vetor de expressão recombinante, célula hospedeira, processo para detectar infecção por m. tuberculosis em uma amostra biológica, kit diagnóstico, anticorpos monoclonal, e, policlonal, e, proteìna de fusão
EP2048505A3 (de) Verfahren zur Früherkennung der Serokonversion eines gegen Hepatitis C-Virus gerichteten Antikörpers
ATE258310T1 (de) Testverfahren für collagenpeptid
DK0747481T3 (da) Epstein-Barr-viruspeptider og antistoffer mod disse peptider
ATE366420T1 (de) Kit und verfahren zur bestimmung von protein esm- 1
ATE343137T1 (de) Verfahren zur bestimmung von polypeptiden
GR3018371T3 (en) Method for identifying or determining proteins and applications therefor.
NO962084L (no) DNA sekvens som koder for en BMP reseptor
ATE288589T1 (de) Verfahren zur analyse von proteinen
DE60013093D1 (de) Methoden und kits zum sequenzieren von polypeptiden
ATE306666T1 (de) Verfahren zur eiweissanalyse
DK0607425T3 (da) Epstein-Barr-viruspeptider og antistoffer mod disse peptider
ATE532796T1 (de) Immunassays zur spezifischen bestimmung von scca- isoformen
CA2259967A1 (en) Peptide reagent for the detection of human cytomegalovirus (cmv)
NO983984L (no) Disintegrin-metalloprotease samt anvendelse derav
ATE228249T1 (de) Immuntest zum nachweis von menschlichen cytomegalovirus spezifischen igm
NO994056L (no) Anvendelse av disintegrin metalloprotease samt mutanter og fragmenter derav
AR013326A1 (es) POLIPEPTIDO AISLADO, MOLECULA DE ADN, VECTOR DE EXPRESION RECOMBINANTE, CELULA HUESPED, METODO PARa DETECTAR LA INFECCION DE M.TUBERCULOSIS EN UNAMUESTRA BIOLOGICA, EQUIPO PARA DIAGNOSTICO, ANTICUERPO MONOCLONAL, Y ANTICUERPO POLICLONAL, PROTEINAS DE FUSION
FI20002225A7 (fi) Diagnostinen menetelmä

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0960336

Country of ref document: EP

REN Ceased due to non-payment of the annual fee